What Insilico Medicine does
Insilico Medicine is a biotechnology company that uses generative AI to accelerate drug discovery and development. It applies AI and bioinformatics across the drug discovery process, from disease modeling and target identification through molecular design and clinical trial analysis.
Key capabilities
The company's Pharma.ai suite includes PandaOmics for disease modeling and target discovery, Chemistry42 for molecular design, Generative Biologics for therapeutic proteins, and inClinico for clinical trial applications. It also offers AI tools for life sciences research, including a domain large language model and research assistant. Insilico combines computational biology with automation to shorten discovery timelines.
Who it's for
Insilico Medicine serves pharmaceutical companies and researchers seeking to reduce the time and cost of drug development. Its platforms support target discovery and chemistry teams, and the company maintains its own therapeutic pipeline spanning conditions such as cancer, inflammatory, and kidney diseases.